NAD+ 1g & Tirzepatide's Successor : A United Kingdom News
The recent interest in NAD+ supplementation, particularly at a substantial dosage of one gram, continues to rise within the United Kingdom pharmaceutical community. Concurrently, attention is firmly fixed on Retatrutide, a novel GLP-1 analogue being viewed by many as a potential replacement to Ti